LadRx starts hunt for new life; Statera lines up merger with diagnostics company
LadRx, formerly known as CytRx, will look for “strategic and financing alternatives,” the cancer biotech said Wednesday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
